Copenhagen Pharma Consulting ApS: Financial statements 2024
CVR: 41537388
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Copenhagen Pharma Consulting ApS (CVR 41537388) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,617,035 and a net result of DKK 558,252 compared with DKK 335,687 the year before. That is a decrease of 10.7% compared with the year before. Equity in the 2024 report amounted to DKK 1,682,299. The solvency ratio was 70%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,617,035
- Profit/Loss
- DKK 558,252
- Equity
- DKK 1,682,299
- Total Assets
- DKK 2,402,040
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.6M | 558K | 1.7M | 2 |
| 2023 | - | 2.9M | 336K | 1.2M | 2 |
| 2022 | - | 1.3M | -38K | 906K | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Copenhagen Pharma Consulting ApS has published its annual report for 2023. Gross profit came to DKK 2,931,273, and the net result was DKK 335,687.
About Copenhagen Pharma Consulting ApS
Copenhagen Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2020. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Lars Holten-Andersen. The company is owned by Obi1 Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,364,006 and a net result of DKK 419,568 compared with DKK 558,252 the year before. Equity in the 2025 report amounted to DKK 601,867.
